Headlands Technologies LLC Acquires Shares of 1,331 UnitedHealth Group Incorporated (NYSE:UNH)

Headlands Technologies LLC acquired a new stake in UnitedHealth Group Incorporated (NYSE:UNH) during the fourth quarter, according to its most recent Form 13F filing with the SEC. The institutional investor acquired 1,331 shares of the healthcare conglomerate’s stock, valued at approximately $701,000.

Other hedge funds have also recently modified their holdings of the company. Verdence Capital Advisors LLC grew its position in shares of UnitedHealth Group by 2.1% in the 4th quarter. Verdence Capital Advisors LLC now owns 16,941 shares of the healthcare conglomerate’s stock valued at $8,919,000 after buying an additional 342 shares during the last quarter. Ascension Capital Advisors Inc. acquired a new stake in UnitedHealth Group during the 3rd quarter worth $216,000. Bellecapital International Ltd. lifted its stake in shares of UnitedHealth Group by 1.4% in the 4th quarter. Bellecapital International Ltd. now owns 13,823 shares of the healthcare conglomerate’s stock worth $7,277,000 after acquiring an additional 193 shares during the period. Great Valley Advisor Group Inc. lifted its stake in shares of UnitedHealth Group by 5.8% in the 3rd quarter. Great Valley Advisor Group Inc. now owns 34,297 shares of the healthcare conglomerate’s stock worth $17,292,000 after acquiring an additional 1,884 shares during the period. Finally, Rise Advisors LLC lifted its stake in shares of UnitedHealth Group by 326.0% in the 4th quarter. Rise Advisors LLC now owns 213 shares of the healthcare conglomerate’s stock worth $112,000 after acquiring an additional 163 shares during the period. 87.86% of the stock is owned by hedge funds and other institutional investors.

Insider Buying and Selling

In related news, EVP Erin Mcsweeney sold 1,236 shares of UnitedHealth Group stock in a transaction on Friday, March 8th. The shares were sold at an average price of $483.48, for a total value of $597,581.28. Following the completion of the sale, the executive vice president now owns 9,364 shares in the company, valued at $4,527,306.72. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. In other UnitedHealth Group news, CAO Thomas E. Roos sold 858 shares of UnitedHealth Group stock in a transaction on Friday, February 23rd. The shares were sold at an average price of $525.79, for a total value of $451,127.82. Following the completion of the transaction, the chief accounting officer now owns 32,289 shares of the company’s stock, valued at $16,977,233.31. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, EVP Erin Mcsweeney sold 1,236 shares of the business’s stock in a transaction on Friday, March 8th. The shares were sold at an average price of $483.48, for a total transaction of $597,581.28. Following the transaction, the executive vice president now directly owns 9,364 shares of the company’s stock, valued at approximately $4,527,306.72. The disclosure for this sale can be found here. Insiders own 0.35% of the company’s stock.

Analyst Ratings Changes

Several analysts have recently commented on the stock. Truist Financial restated a “buy” rating and issued a $600.00 target price on shares of UnitedHealth Group in a research note on Wednesday, April 17th. Erste Group Bank reiterated a “hold” rating on shares of UnitedHealth Group in a report on Wednesday, March 13th. TD Cowen cut their price target on shares of UnitedHealth Group from $607.00 to $546.00 and set a “buy” rating for the company in a report on Wednesday, April 10th. StockNews.com downgraded shares of UnitedHealth Group from a “buy” rating to a “hold” rating in a report on Thursday, April 18th. Finally, Stephens restated an “overweight” rating and set a $605.00 target price on shares of UnitedHealth Group in a report on Thursday, February 8th. Four equities research analysts have rated the stock with a hold rating and fifteen have given a buy rating to the stock. Based on data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and an average price target of $570.05.

UnitedHealth Group Stock Up 0.3 %

Shares of UNH traded up $1.49 during mid-day trading on Friday, reaching $495.35. 2,727,016 shares of the stock traded hands, compared to its average volume of 5,623,667. The firm has a market cap of $455.76 billion, a price-to-earnings ratio of 30.28, a P/E/G ratio of 1.43 and a beta of 0.54. The stock has a fifty day simple moving average of $485.84 and a 200 day simple moving average of $514.21. UnitedHealth Group Incorporated has a 12-month low of $436.38 and a 12-month high of $554.70. The company has a quick ratio of 0.79, a current ratio of 0.85 and a debt-to-equity ratio of 0.69.

UnitedHealth Group (NYSE:UNH) last posted its quarterly earnings data on Tuesday, April 16th. The healthcare conglomerate reported $6.91 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $6.63 by $0.28. The company had revenue of $99.80 billion for the quarter, compared to analyst estimates of $99.23 billion. UnitedHealth Group had a net margin of 4.05% and a return on equity of 26.50%. The business’s quarterly revenue was up 8.6% on a year-over-year basis. During the same quarter last year, the firm posted $6.26 earnings per share. Sell-side analysts expect that UnitedHealth Group Incorporated will post 27.61 EPS for the current fiscal year.

UnitedHealth Group Announces Dividend

The business also recently declared a quarterly dividend, which was paid on Tuesday, March 19th. Investors of record on Monday, March 11th were paid a $1.88 dividend. The ex-dividend date of this dividend was Friday, March 8th. This represents a $7.52 dividend on an annualized basis and a dividend yield of 1.52%. UnitedHealth Group’s dividend payout ratio (DPR) is presently 45.97%.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.